Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in Gastroenterology Clinics of North America
- Vol. 40 (1), 207-222
- https://doi.org/10.1016/j.gtc.2010.12.009
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without ConstipationThe New England Journal of Medicine, 2011
- Bacterial competition: surviving and thriving in the microbial jungleNature Reviews Microbiology, 2009
- Human gut microbiota in obesity and after gastric bypassProceedings of the National Academy of Sciences of the United States of America, 2009
- Microbes in Gastrointestinal Health and DiseaseGastroenterology, 2009
- The Human Intestinal Microbiome: A New Frontier of Human BiologyDNA Research, 2009
- Alterations in Mucosal Immunity Identified in the Colon of Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2008
- Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118Proceedings of the National Academy of Sciences of the United States of America, 2007
- Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunumGut, 2007
- Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to dateNeurogastroenterology & Motility, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006